MedTrace Logo

Closed-loop Insulin Delivery In Type 1 Diabetes Pregnancies (CIRCUIT)

NCT04902378 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 94

Last updated 2025-06-05

No results posted yet for this study

Summary

This trial will assess the efficacy of the Tandem t:slim X2 insulin pump with Control IQ technology compared with standard insulin delivery plus CGM in pregnant women with type 1 diabetes.

Conditions

  • Type 1 Diabetes Mellitus
  • Pregnancy Related
  • Glucose Metabolism Disorders
  • Metabolic Disease
  • Endocrine System Diseases

Interventions

DEVICE

Tandem t:slim X2 insulin pump with Control IQ technology

The intervention group will be fitted with the Tandem t:slim X2 insulin pump with Control IQ technology during pregnancy.

Sponsors & Collaborators

  • University of Calgary

    lead OTHER

Principal Investigators

  • Lois Donovan, MD · University of Calgary

  • Denice Feig, MD · MOUNT SINAI HOSPITAL

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-15
Primary Completion
2025-05-23
Completion
2025-05-23

Countries

  • Australia
  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04902378 on ClinicalTrials.gov